[ad_1]
The United States Food and Drug Administration (FDA) announced for the first time that it approved an antiviral drug for use in treating the new type of coronavirus (Kovid-19).
California-based Gilead Sciences Inc. The company’s drug “Veklury” was approved by the FDA for use in the treatment of Kovid-19 after it was seen in a large-scale study conducted by the National Institutes of Health. from the USA to shorten the payback period by five days.
In the FDA statement, “Veklury is approved for the treatment of people who are at least 12 years old and over 40 kilos who are hospitalized for coronavirus infection.” expression was used.
Veklury, which was previously allowed to be used in emergency situations for patients whose coronavirus treatment continues in the hospital, was the first drug approved by the FDA for use in the treatment of Kovid-19.
The manufacturer also reported that the drug blocks a substance that the coronavirus uses to reproduce its own copies in the body and that patients must first have kidney and liver tests to be sure it is safe.
It was said that if the drug is not taken with hydroxychloroquine used in the treatment of malaria, its effect may decrease.
The drug, which has been approved in nearly 50 countries and has temporary permission, was also used by US President Donald Trump.
